93 results on '"Becker, Jürgen C."'
Search Results
2. S1‐Leitlinie Talgdrüsenkarzinom
3. Merkel Cell Carcinoma
4. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention
5. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention
6. S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen
7. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“– update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
8. Prognostic factors in the primary care of patients with Merkel cell carcinoma: A monocentric cohort study of 108 patients from a tertiary referral centre
9. S2k‐Leitlinie – Merkelzellkarzinom – Update 2022
10. S2k Guideline – Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – Update 2022
11. S1 Guidelines for the Kaposi Sarcoma
12. S1‐Leitlinie: Kaposi‐Sarkom
13. Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients
14. S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
15. S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021
16. Patched 1 expression in Merkel cell carcinoma
17. Differences in site‐specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007‐2015
18. A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms
19. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease
20. S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit
21. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators
22. S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren
23. Neues zum kutanen Plattenepithelkarzinom
24. S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – update 2018
25. S2k‐Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) – Update 2018
26. Characterization of six Merkel cell polyomavirus‐positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration
27. A short-term in vivo model for Merkel Cell Carcinoma
28. Checkpoint‐Inhibitor nun auch zur Therapie des metastasierten Merkelzellkarzinoms zugelassen
29. S2k guideline: HPV-associated lesions of the external genital region and the anus - anogenital warts and precancerous lesions of the vulva, the penis, and the peri- and intra-anal skin (short version)
30. S2k-Leitlinie: HPV-assoziierte Läsionen der äußeren Genitalregion und des Anus - Genitalwarzen und Krebsvorstufen der Vulva, des Penis und der peri- und intraanalen Haut (Kurzfassung)
31. S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86)
32. S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86)
33. S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)
34. S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86)
35. Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim Melanom
36. Update on the clinical use of kinase inhibitors in melanoma
37. Merkel Cell Carcinoma
38. Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis
39. Fluorescencein situhybridization and qPCR to detect Merkel cell polyomavirus physical status and load in Merkel cell carcinomas
40. Tumor-educated myeloid cells: impact the micro- and macroenvironment
41. Brief S2k guidelines – Merkel cell carcinoma
42. S2k Kurzleitlinie - Merkelzellkarzinom
43. Therapie der fortgeschrittenen kutanen T‐Zell‐Lymphome mit nichtpegyliertem liposomalem Doxorubicin – Konsensus der Lymphomgruppe der Arbeitsgemeinschaft Dermatologische Onkologie
44. Treatment of advanced cutaneous T‐cell lymphomas with non‐pegylated liposomal doxorubicin – Consensus of the lymphoma group of the Working Group Dermatologic Oncology
45. Survivin downregulation is not required for T antigen knockdown mediated cell growth inhibition in MCV infected merkel cell carcinoma cells
46. Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases
47. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells
48. Management kutaner Nebenwirkungen von EGFR-Inhibitoren: Empfehlungen eines deutschen Expertengremiums für den primär behandelnden Arzt
49. Homo‐ and heterotypic cell–cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching
50. A novel xenograft model of cutaneous T-cell lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.